In patients with coronary artery disease (CAD), high-sensitivity C-reactive protein (hs-CRP) and myeloperoxidase (MPO) are each predictive for cardiovascular mortality, and patients with elevated levels of both markers experience a 4.33-fold increase in risk.

Authors

• Person: Not available Organization: National Lipid Association
  EBM Tools for Practice: Best Biomarkers for Inflammation

Sources

• EBM Tools for Practice: Best Biomarkers for Inflammation www.lipid.org National Lipid Association via serper

Referenced by nodes (3)

• high-sensitivity C-reactive protein concept
• coronary artery disease concept
• cardiovascular mortality concept